The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group

The New England Journal of Medicine
Jan Albert KuivenhovenJohn J P Kastelein

Abstract

The high-density lipoprotein (HDL) cholesterol concentration is inversely related to the risk of coronary artery disease. The cholesteryl ester transfer protein (CETP) has a central role in the metabolism of this lipoprotein and may therefore alter the susceptibility to atherosclerosis. The DNA of 807 men with angiographically documented coronary atherosclerosis was analyzed for the presence of a polymorphism in the gene coding for CETP. The presence of this DNA variation was referred to as B1, and its absence as B2. All patients participated in a cholesterol-lowering trial designed to induce the regression of coronary atherosclerosis and were randomly assigned to treatment with either pravastatin or placebo for two years. The B1 variant of the CETP gene was associated with both higher plasma CETP concentrations (mean [+/-SD], 2.29+/-0.62 microg per milliliter for the B1B1 genotype vs. 1.76+/-0.51 microg per milliliter for the B2B2 genotype) and lower HDL cholesterol concentrations (34+/-8 vs. 39+/-10 mg per deciliter). In addition, we observed a significant dose-dependent association between this marker and the progression of coronary atherosclerosis in the placebo group (decrease in mean luminal diameter: 0.14+/-0.21 mm for t...Continue Reading

References

Sep 16, 1992·JAMA : the Journal of the American Medical Association·H BuchwaldJ K Bissett
May 1, 1991·The Journal of Clinical Investigation·E QuinetL Rudel
Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Jun 11, 1987·Nucleic Acids Research·D Drayna, R Lawn
Jan 1, 1995·Annual Review of Biochemistry·A Tall
Nov 15, 1993·Annals of Internal Medicine·D H BlankenhornUNKNOWN MARS Research Group
Apr 1, 1993·Circulation·D WatersJ Lespérance
Jul 1, 1995·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·B FögerJ R Patsch
Jun 15, 1996·The Journal of Clinical Investigation·C J Fielding, R J Havel
Nov 1, 1996·The American Journal of Medicine·R A Kreisberg
Mar 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·J A KuivenhovenP H Pritchard

❮ Previous
Next ❯

Citations

Oct 3, 2006·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·J KirchheinerJ Brockmöller
Jan 29, 2008·European Journal of Clinical Pharmacology·Jürgen Brockmöller, Mladen V Tzvetkov
Sep 7, 2011·Age·Jonatan R RuizAlejandro Lucia
Apr 5, 2001·Current Atherosclerosis Reports·J M Ordovas
Apr 5, 2002·Current Atherosclerosis Reports·Jose M Ordovas, Haiqing Shen
Aug 7, 2002·Current Atherosclerosis Reports·Margaret E Brousseau, Ernst J Schaefer
Apr 7, 2005·Current Atherosclerosis Reports·François Cambien
Apr 7, 2005·Current Atherosclerosis Reports·Anke-Hilse Maitland-van der Zee, Eric Boerwinkle
Dec 21, 2000·Current Atherosclerosis Reports·J M Ordovas, E J Schaefer
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
Apr 10, 2013·PharmacoEconomics·Michael J SorichBrita Pekarsky
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Kimiya MaedaHisashi Shinkai
Nov 14, 2003·Current Problems in Cardiology·Debabrata Mukherjee, Eric J Topol
Dec 12, 2003·Metabolism: Clinical and Experimental·Katsunori IkewakiUNKNOWN Japan CETP Study Group
Jun 20, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·G SchmitzK J Lackner
Dec 1, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·Werner Steimer, Julia M Potter
Jan 3, 2001·European Journal of Pharmacology· Maitland-van der Zee AHH G Leufkens
Apr 8, 2003·European Journal of Pharmacology·Hiroshi OkamotoKorekiyo Wakitani
Jun 8, 2002·Atherosclerosis·Anke Hilse Maitland-van der ZeeAnthonius de Boer
Jul 16, 2003·Atherosclerosis·Michael H DavidsonUna Ryan
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein
Jun 14, 2003·Pharmacology & Therapeutics·Anthony S WierzbickiAlbert Ferro

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.